JP2013521233A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521233A5 JP2013521233A5 JP2012555201A JP2012555201A JP2013521233A5 JP 2013521233 A5 JP2013521233 A5 JP 2013521233A5 JP 2012555201 A JP2012555201 A JP 2012555201A JP 2012555201 A JP2012555201 A JP 2012555201A JP 2013521233 A5 JP2013521233 A5 JP 2013521233A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- patient
- immunotherapy targeting
- pet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30825310P | 2010-02-25 | 2010-02-25 | |
| US61/308,253 | 2010-02-25 | ||
| PCT/US2011/026365 WO2011106732A1 (en) | 2010-02-25 | 2011-02-25 | Pet monitoring of ab-directed immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093421A Division JP2016185964A (ja) | 2010-02-25 | 2016-05-06 | Ａβを標的とする免疫療法のＰＥＴモニタリング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013521233A JP2013521233A (ja) | 2013-06-10 |
| JP2013521233A5 true JP2013521233A5 (https=) | 2014-09-25 |
Family
ID=44507245
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012555201A Pending JP2013521233A (ja) | 2010-02-25 | 2011-02-25 | Ａβを標的とする免疫療法のＰＥＴモニタリング |
| JP2016093421A Pending JP2016185964A (ja) | 2010-02-25 | 2016-05-06 | Ａβを標的とする免疫療法のＰＥＴモニタリング |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093421A Pending JP2016185964A (ja) | 2010-02-25 | 2016-05-06 | Ａβを標的とする免疫療法のＰＥＴモニタリング |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20130084245A1 (https=) |
| EP (1) | EP2538982A4 (https=) |
| JP (2) | JP2013521233A (https=) |
| WO (1) | WO2011106732A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| WO2006066089A1 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
| US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
| PT2182983E (pt) | 2007-07-27 | 2014-09-01 | Janssen Alzheimer Immunotherap | Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
| SI2579042T1 (sl) | 2011-10-04 | 2014-09-30 | Affiris Ag | Postopek za detektiranje Ass-specifičnih protiteles v biološkem vzorcu |
| JP6100792B2 (ja) | 2011-11-16 | 2017-03-22 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 灰白質における脳アミロイドを算出及び表示する方法 |
| RU2014153675A (ru) * | 2012-07-03 | 2016-08-27 | Янссен Альцгеймер Иммунотерапи | Антитела к с-концевым и центральным эпитопам а-бета |
| CN106831799B (zh) * | 2016-12-20 | 2018-12-21 | 四川大学 | 羟基苯乙烯吡啶曼尼希碱类化合物、其制备方法和用途 |
| KR102031652B1 (ko) * | 2018-01-19 | 2019-10-14 | 서울대학교산학협력단 | 전이체 단백질 과발현 관련 질환의 양성자방출단층촬영 방사성추적자, 형광영상 진단 및 광역학 치료를 위한 전이체 단백질 표적 리간드 및 이의 제조방법 |
| EP3759121A1 (en) | 2018-03-01 | 2021-01-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
| MX2021000778A (es) * | 2018-07-24 | 2021-03-31 | Eisai R&D Man Co Ltd | Metodos de tratamiento y prevencion de la enfermedad de alzheimer. |
| CN112584767A (zh) * | 2018-08-21 | 2021-03-30 | 皇家飞利浦有限公司 | 淀粉样蛋白筛查的方法和装置 |
| US20230027014A1 (en) * | 2019-11-12 | 2023-01-26 | Ambetex Pty Ltd | Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2275570T3 (es) | 1999-12-08 | 2007-06-16 | Intellect Neurosciences, Inc. | Peptidos amiloides beta quimericos. |
| ES2389811T3 (es) | 2000-06-28 | 2012-10-31 | Prana Biotechnology Limited | Oligómeros de amiloide beta para uso en el tratamiento, el alivio o la prevención de la enfermedad de Alzheimer |
| EP1309341A2 (en) | 2000-07-07 | 2003-05-14 | Lars Lannfelt | Prevention and treatment of alzheimer's disease |
| US6395837B1 (en) | 2000-08-03 | 2002-05-28 | King Industries, Inc. | Alkylated aryl disulfonic acid catalysts for crosslinking polyethylene |
| SI1524994T1 (sl) | 2002-07-19 | 2011-08-31 | Cytos Biotechnology Ag | Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US20040242845A1 (en) | 2003-02-21 | 2004-12-02 | Nicolau Yves Claude | Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them |
| US20050123553A1 (en) | 2003-07-30 | 2005-06-09 | Alon Monsonego | Amyloid beta-peptide and methods of use |
| US20050214222A1 (en) * | 2004-02-13 | 2005-09-29 | Mckinnon Stuart J | In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes |
| CA2830939C (en) * | 2004-07-02 | 2017-02-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of thioflavin radiolabelled derivatives in amyloid imaging for identifying patients prodromal to a disease associated with amyloid deposition |
| AT413946B (de) | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| NZ562434A (en) | 2005-05-05 | 2010-04-30 | Merck & Co Inc | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| WO2008114801A1 (en) * | 2007-03-12 | 2008-09-25 | National Institute Of Radiological Sciences | Pet visualization of amyloid-associated neuroinflammation in the brain |
| US20080292625A1 (en) * | 2007-04-18 | 2008-11-27 | Sally Schroeter | Prevention and treatment of cerebral amyloid angiopathy |
| PT2182983E (pt) * | 2007-07-27 | 2014-09-01 | Janssen Alzheimer Immunotherap | Tratamento de doenças amiloidogénicas com anticorpos anti-abeta humanizados |
| JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
-
2011
- 2011-02-25 JP JP2012555201A patent/JP2013521233A/ja active Pending
- 2011-02-25 EP EP11748201.8A patent/EP2538982A4/en not_active Withdrawn
- 2011-02-25 WO PCT/US2011/026365 patent/WO2011106732A1/en not_active Ceased
- 2011-02-25 US US13/580,866 patent/US20130084245A1/en not_active Abandoned
-
2016
- 2016-05-06 JP JP2016093421A patent/JP2016185964A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521233A5 (https=) | ||
| Lobello et al. | Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer′ s Disease | |
| JP2023011002A (ja) | アルツハイマー病の治療法 | |
| AU2019264073B2 (en) | 2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting ASM activity, and use thereof | |
| Berk et al. | Successes and failures for drugs in late-stage development for Alzheimer’s disease | |
| US20130084245A1 (en) | Pet monitoring of a-beta-directed immunotherapy | |
| JP2022145965A (ja) | アルツハイマー病を治療する方法 | |
| TWI549690B (zh) | 包含抗－ｃｄ１９類美登素（ｍａｙｔａｎｓｉｎｏｉｄ）免疫結合物及利妥昔單抗（ｒｉｔｕｘｉｍａｂ）之用於治療ｃｄ１９＋ｂ－細胞惡性症狀之組合療法 | |
| Maya et al. | Novel radioiodinated aurones as probes for SPECT imaging of β-amyloid plaques in the brain | |
| JP2015526409A5 (https=) | ||
| US20190282714A1 (en) | Radioligands for imaging the ido1 enzyme | |
| CA3211944A1 (en) | Anti-amyloid beta antibodies and uses thereof | |
| TW202231661A (zh) | 安全投予抗ｔａｕ抗體之方法 | |
| KR20250078929A (ko) | 알츠하이머병 치료를 위한 면역치료법과 사일로이노시톨 병용 | |
| CA2966582A1 (en) | Low dosage a2a antagonist for the treatment of adhd and parkinsons | |
| US9180212B2 (en) | β-amyloid plaque imaging agents | |
| JP2013237655A (ja) | コンフォメーション病診断用分子プローブ | |
| Loureiro et al. | New Perspectives for Treatment in Alzheimer’s Disease | |
| Ferrer et al. | Towards early detection and treatment of Alzheimer’s disease | |
| Furumoto et al. | Synthesis and Preclinical Evaluation of a Fluorine-18 Labeled BF-227 Derivative | |
| EA051351B1 (ru) | Способ лечения болезни альцгеймера |